Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and coronary artery disease (CAD) is the cardiac manifestation of metabolic syndrome. NAFLD is strongly linked to CAD and hepatic steatosis is an independent risk factor for CAD and cardiac morta...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Rohini, Otgonsuren, Munkzhul, Younoszai, Zahra, Allawi, Hussain, Raybuck, Bryan, Younossi, Zobair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964159/
https://www.ncbi.nlm.nih.gov/pubmed/27493762
http://dx.doi.org/10.1136/bmjgast-2016-000096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964159/
https://www.ncbi.nlm.nih.gov/pubmed/27493762
http://dx.doi.org/10.1136/bmjgast-2016-000096

Ejemplares similares